Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients

Dysbiosis in the gut microbiome, particularly concerning the synchronous crosstalk between the gut and the liver, has been associated with various diseases. This study profiles the gut microbiome in liver diseases among Egyptian patients, with a focus on the hepatitis C virus (HCV) and hepatocellula...

Full description

Saved in:
Bibliographic Details
Main Author: Zahra, Marwa A
Format: Thesis
Published: AUC Knowledge Fountain 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613431793713152
access_status_str Open Access
author Zahra, Marwa A
author_browse Zahra, Marwa A
author_facet Zahra, Marwa A
author_sort Zahra, Marwa A
collection Thesis
description Dysbiosis in the gut microbiome, particularly concerning the synchronous crosstalk between the gut and the liver, has been associated with various diseases. This study profiles the gut microbiome in liver diseases among Egyptian patients, with a focus on the hepatitis C virus (HCV) and hepatocellular carcinoma (HCC), both of which are highly prevalent in Egypt. Utilizing shotgun metagenomic sequencing, we analyzed microbial gene catalogs and taxonomic profiles from 46 Egyptian patients categorized into five groups: healthy individuals, liver disease patients of different etiologies, post-HCV, treated HCV, and HCV-HCC patients. Healthy and treated HCV patients exhibited distinct microbial profiles characterized by an abundance of beneficial bacteria, Faecalibacterium and Bifidobacterium (p < 0.05), associated with anti-inflammatory shortchain fatty acid production. Conversely, liver disease and HCC patients displayed increased pathogenic bacteria, Escherichia (p < 0.05), and genes linked to inflammation and oncogenesis, including lipopolysaccharide biosynthesis. These findings suggest a dominance of Faecalibacterium in healthy Egyptians, likely attributable to fiber-rich diets, and cytochrome P450 genes as potential HCC biomarkers, possibly connected to aflatoxin exposure. Treated HCV patients showed significant microbiome recovery, reflecting effective antiviral therapy. These findings emphasize that Egypt-specific factors, such as persistent resistance genes post-HCV due to antibiotic use and the prominence of bile acid metabolism genes, are influenced by high HCV prevalence and environmental exposures like aflatoxins. Taken together, the results highlight the need for region-specific microbiome research priorities in Egypt and underscore how local dietary, clinical, and environmental factors may shape future objectives in understanding liver disease pathogenesis and prevention.
format Thesis
id oai:fount.aucegypt.edu:etds-3725
institution American University in Cairo (Egypt)
last_indexed 2026-06-10T12:35:59.828Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from AUC Knowledge Fountain — bepress
publishDate 2026
publishDateRange 2026
publishDateSort 2026
publisher AUC Knowledge Fountain
publisherStr AUC Knowledge Fountain
record_format dspace
source_str AUC Knowledge Fountain — bepress
spelling oai:fount.aucegypt.edu:etds-3725 Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients Zahra, Marwa A Dysbiosis in the gut microbiome, particularly concerning the synchronous crosstalk between the gut and the liver, has been associated with various diseases. This study profiles the gut microbiome in liver diseases among Egyptian patients, with a focus on the hepatitis C virus (HCV) and hepatocellular carcinoma (HCC), both of which are highly prevalent in Egypt. Utilizing shotgun metagenomic sequencing, we analyzed microbial gene catalogs and taxonomic profiles from 46 Egyptian patients categorized into five groups: healthy individuals, liver disease patients of different etiologies, post-HCV, treated HCV, and HCV-HCC patients. Healthy and treated HCV patients exhibited distinct microbial profiles characterized by an abundance of beneficial bacteria, Faecalibacterium and Bifidobacterium (p < 0.05), associated with anti-inflammatory shortchain fatty acid production. Conversely, liver disease and HCC patients displayed increased pathogenic bacteria, Escherichia (p < 0.05), and genes linked to inflammation and oncogenesis, including lipopolysaccharide biosynthesis. These findings suggest a dominance of Faecalibacterium in healthy Egyptians, likely attributable to fiber-rich diets, and cytochrome P450 genes as potential HCC biomarkers, possibly connected to aflatoxin exposure. Treated HCV patients showed significant microbiome recovery, reflecting effective antiviral therapy. These findings emphasize that Egypt-specific factors, such as persistent resistance genes post-HCV due to antibiotic use and the prominence of bile acid metabolism genes, are influenced by high HCV prevalence and environmental exposures like aflatoxins. Taken together, the results highlight the need for region-specific microbiome research priorities in Egypt and underscore how local dietary, clinical, and environmental factors may shape future objectives in understanding liver disease pathogenesis and prevention. 2026-02-15T08:00:00Z dissertation application/pdf https://fount.aucegypt.edu/etds/2666 https://fount.aucegypt.edu/context/etds/article/3725/viewcontent/auto_convert.pdf Theses and Dissertations AUC Knowledge Fountain Hepatocellular Carcinoma HCV Microbiome Gut Whole-Metagenome Seqeuencing metagenomics Egypt Biotechnology Genomics Molecular Genetics Pathogenic Microbiology
spellingShingle Hepatocellular Carcinoma
HCV
Microbiome
Gut
Whole-Metagenome Seqeuencing
metagenomics
Egypt
Biotechnology
Genomics
Molecular Genetics
Pathogenic Microbiology
Zahra, Marwa A
Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients
title Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients
title_full Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients
title_fullStr Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients
title_full_unstemmed Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients
title_short Metagenomic Profiling of Gut Microbiome Signatures Across Liver Disease Stages and HCV-Related Hepatocellular Carcinoma in Egyptian Patients
title_sort metagenomic profiling of gut microbiome signatures across liver disease stages and hcv related hepatocellular carcinoma in egyptian patients
topic Hepatocellular Carcinoma
HCV
Microbiome
Gut
Whole-Metagenome Seqeuencing
metagenomics
Egypt
Biotechnology
Genomics
Molecular Genetics
Pathogenic Microbiology
url https://fount.aucegypt.edu/etds/2666
https://fount.aucegypt.edu/context/etds/article/3725/viewcontent/auto_convert.pdf
work_keys_str_mv AT zahramarwaa metagenomicprofilingofgutmicrobiomesignaturesacrossliverdiseasestagesandhcvrelatedhepatocellularcarcinomainegyptianpatients